Sign In
Section Navigation
Common TitleBI-1182.2
Official Title Tipranavir Disodium: An Open-Label Exploratory Study of Tipranavir and Ritonavir in Combination With One Nucleoside Reverse Transcriptase Inhibitor and One Non-Nucleoside Reverse Transcriptase Inhibitor in Multiple Protease Inhibitor-Experienced HIV Patients
Phase Phase II
ClinicalTrials.gov NCT02238314
Treatments
Tipranavir
Tipranavir Aptivus

Tipranavir

Tradename:AptivusOther Names:TPVClass:Protease Inhibitors (PI)
Categories Treatment-Experienced
Funding
IndustryBoehringer Ingelheim
References
  • Markowitz M, Slater LN, Schwartz R, et al. Long-term efficacy and safety of tipranavir boosted with ritonavir in HIV-1-infected patients failing multiple protease inhibitor regimens: 80-week data from a phase 2 study. J Acquir Immune Defic Syndr. 2007;45:401-10.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.